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AD-MSCsThe present study was conducted to compare between the therapeutic efﬁcacies of human amni-
otic membrane-derived stem cells (hAM-MSCs) vs. adipose tissue derived stem cells (AD-
MSCs) in cyclophosphamide (CTX)-induced ovarian failure in rats. Forty-eight adult female
rats were included in the study; 10 rats were used as control group. Thirty-eight rats were
injected with CTX to induce ovarian failure and divided into four groups: ovarian failure
(IOF) (IOF group), IOF + phosphate buffer saline (PBS group), IOF+ hAM-MSCs group
and IOF+ AD-MSCs group. Serum levels of FSH and estradiol (E2) were assessed.
Histopathological examination of the ovarian tissues was performed and quantitative gene
expressions of Oct-4, Stra8 and integrin beta-1 genes were conducted by quantitative real time
PCR. Results showed that IOF and IOF+ PBS rat groups exhibited decreased ovarian folli-
cles, increased interstitial ﬁbrosis with signiﬁcant decrease of serum E2, signiﬁcant increase
serum FSH level and signiﬁcant down-regulation of Stra8 and integrin beta-1. In hAM-MSCs
and AD-MSCs rat groups, there were increased follicles and corpora with evident the presence
of oocytes, signiﬁcant increase in serum E2, signiﬁcant decrease in serum FSH levels (in hAM-
MSCs treated group only) and signiﬁcant up-regulation of the three studied genes with higher
levels in hAM-MSCs treated rats group when compared to AD-MSCs treated rats group. In
Conclusion, administration of either hAM-derivedMSCs or AD-MSCs exerts a signiﬁcant ther-
apeutic efﬁcacy in chemotherapy induced ovarian insult in rats. hAM-MSCs exert higher ther-
apeutic efﬁcacy as compared to AD-MSCs.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Cairo University.Introduction
Premature ovarian failure (POF) or premature ovarian insufﬁ-
ciency (POI) is deﬁned as cessation of menstrual periods
(amenorrhea for 4 months or more), increased levels of FSH
to menopausal level (usually over 40 IU L1 obtained on 2
occasions at least 1 month apart), and diminished levels of
234 H. Fouad et al.estrogens (estradiol levels less than 50 pg mL1) before the age
of 40 [1].
At present about 25% of all forms of POF can be classiﬁed
as iatrogenic and related to cancer treatment [2] such as
chemotherapy or radiotherapy. Also, POI may be caused by
autoimmunity, genetic factors as Turner’s syndrome, fragile
X syndrome and inhibin alpha (INHA) gene affection. In
addition, metabolic disorders such as classic galactosemia,
virus infection such as HIV and mumps, toxins and lifestyle
factors such as cigarette smoking are associated with the devel-
opment of POI [3]. However, the majority of cases remain
idiopathic.
Bone marrow derived MSCs (BM-MSCs) are the most
common source of clinically used MSCs. However, adult BM
has limitations; it needs invasive harvesting which is accompa-
nied by a risk of infection. It yields a small number of cells. In
addition, the number, differentiation potential, and life span of
BM-MSCs decline with patient age [4].
Amniotic membrane (AM)-derived stem cells are isolated
from amnion that is normally discarded. These cells are there-
fore readily available, and ethical concerns regarding the isola-
tion of stem cells from the amniotic membrane are minimized
[5]. In addition to that, amniotic stem cells have not been found
to form teratomas when transplanted in vivo [6]. Furthermore,
hAM-MSCs may be considered superior to adult MSCs in their
proliferation and differentiation potential [6].
hAM-MSCs express pluripotency markers including OCT4,
SOX2, and NANOG [7], high expansion in vitro and multilin-
eage differentiation capacity potential into cells derived from
the three germ layers [8]. However, at this time whether
hAM-MSCs can restore ovarian function is unclear.
Oct-4 gene is required for primordial germ cell survival and
loss of Oct4 function leads to apoptosis of primordial germ cells
(PGCs) so it is essential for maintaining viability of mammalian
germ line [9]. The discovery of the essential role of Oct4 in
induced pluripotent stem (iPS) cell technology further highlights
its irreplaceable function in establishing pluripotency [10].
Integrins are transmembrane receptors that link the extra-
cellular matrix (ECM) environment with intracellular signal-
ing, thus regulating multiple cell functions such as cell
survival, proliferation, migration, and differentiation. CD29
(integrin beta-1) gene expression is believed to be crucial for tis-
sue repair [11].
Stra8 is a gene that is speciﬁcally expressed in mammalian
germ cells before their transition from mitosis to meiosis [12].
It is a regulator of meiotic initiation in females [13] so it is con-
sidered a meiotic inducer [14] and a pre-meiosis speciﬁc marker
[15].
To address stem cells’ therapeutic potential in ovarian fail-
ure we compared the therapeutic efﬁcacy between isolated
hAM-MSCs (cells from fetal tissues) and human ADMSCs
(cells from adult tissues) in supporting follicular development,
hormonal production by the ovary and expression of pluripo-
tent markers, germ cells markers and anchoring receptors in
experimental animal model of chemotherapy induced ovarian
failure.Material and methods
This study is a prospective case control animal study per-
formed in the Faculty of Medicine, Cairo University, at theUnit of Biochemistry and Molecular Biology. The design of
this work was divided into 2 steps: in vitro and in vivo study.
In vitro study
Isolation and propagation of hAM-MSCs and AD-MSCs from
human source
Placentas were freshly collected postpartum from Gynecology
and Obstetric Department, Faculty of Medicine Cairo
University. The amniotic membranes were mechanically sepa-
rated from placentas taken from normal full-term uncompli-
cated elective cesarean sections after obtaining a written
informed consent. They were transported in cold phosphate
buffer saline (PBS; Gibco/Invitrogen, Grand Island, New
York, USA) solution in a thermally insulated container on
ice. The amniotic membranes were processed within 1 h and
subjected to collagenase II enzymatic digestion. Collagenase
II solution was prepared at 100 U/mL in DMEM and 15 mL
of collagenase II solution was added to the amniotic mem-
branes and incubated for 2 h at 37 C in 5% CO2 atmosphere
with occasional shaking. Digested amniotic membranes were
ﬁltered through a 40 lm cell strainer to remove large tissue
aggregates.
After enzyme digestion and ﬁltration, cells were washed in
phosphate-buffered saline (PBS) (Cellgro, USA) and cen-
trifuged at 350 g for 5 min. The cell pellet was resuspended
in the basal culture medium, low glucose Dulbecco’s
Modiﬁed Eagle’s Medium (LG-DMEM; Gibco BRL, USA)
containing 10% FBS (Fetal bovine serum; Gibco BRL,
USA). The cells were seeded into T75 polystyrene cell culture
ﬂasks (Nunc, USA) and incubated in a humidiﬁed atmosphere
with 5% CO2. The basal culture medium was changed 3 times
a week and passaged once the cells reached 80–90% conﬂuency
[16].
Human adipose tissue was collected by human abdominal
subcutaneous adipose tissue aspiration during surgery after
obtaining an informed medical consent. It was transported
on ice insulated container. The adipose tissue was washed
extensively with PBS to remove contaminating debris and
red blood cells then minced with scissors and enzymatic diges-
tion was performed as described with amniotic membranes
with collagenase II in PBS for 60 min at 37 C with gentle agi-
tation. Digested tissue was ﬁltered through a 200-lm mesh ﬁl-
ter to remove debris and centrifuged at 600 g for 5 min to
obtain cellular pellets. Erythrocytes were removed by treat-
ment with erythrocyte lysis buffer. The cells were cultured as
described for the cells isolated from amniotic membranes [17].
Labeling the MSCs to detect their homing into the ovarian tissue
in the animal model
MSCs were labeled with PKH26 Red Fluorescent Cell Linker
Kit (Sigma–Aldrich) and injected into the tail vein of rats.
After one month of injection, the ovarian tissue was examined
with a ﬂuorescence microscope to detect the cells stained with
PKH26 dye to ensure homing and trace the injected cells in the
ovarian tissue.
Characterization of isolated human hAM-MSCs and AD-MSCs
Quantitative expression of mesenchymal stem cells, amniotic
membrane and adipose tissue markers was conducted with
using CYTOMICS FC 500 Flow Cytometer (Beckman coulter,
Table 1 PCR primers sequence.
Oct-4 Forward primer: 50 CCTGCAGCAGATCACTAGCAT 30
(POU class 5 homeobox 1, Pou5f1) GenBank
Accession Number NM_001009178.1
Reverse primer: 50 CACTCGAACCACATCCCTCT 30
CD29 (integrin beta-1) GenBank
Accession Number NM_017022.2
Forward primer: 50 GACCCCTCCGAGAGGCGGAA 30
Reverse primer: 50 TGGCCGGAGCTTCTCTGCCAT 30
Stimulated by retinoic acid gene 8 (Stra8) Forward primer: 50 CAGATCATCGAGTTTTTCAAAGG 30
GenBank Accession Number XM_001067836.1 Reverse primer: 50 TCCACAGGAGGATCTGGTTC 30
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) Forward primer: 50-GAAGGTGAAGGTCGGAGTCA-30
Gene Bank accession number NC_000019.9 Reverse primer: 50-GAAGATGGTGATGGGATTTC-30
Amniotic membrane stem cells vs. adipose stem cells in ovarian failure 235FL, USA) and analyzed using CXP Software version 2.2.
Monoclonal antibodies used were CD45 FITC, CD34 PE,
CD 29 PE, CD 44 PE, CD 90 PE, and CD 73 PE.
In vivo study
Experimental animals
The study included ﬁfty mature white albino female rats of
proven fertility from an inbred colony (Curl: HEL1) of
matched age and weight at the Kasr Al-Aini animal experi-
mental unit, Faculty of Medicine, Cairo University. Their
median age at the beginning of the experiment was 6 months
with a range from 5–7 months and their median weight was
200 g with a range 170–230 g. The rats were inbred in the
Experimental Animal Unit, Faculty of Medicine, Cairo
University. All animals were maintained according to the stan-
dard guidelines of Institutional Animal Care and Use
Committee. They were maintained in an air-conditioned ani-
mal house with speciﬁc pathogen-free conditions. They were
kept 5 per cage. Animals were fed a semi-puriﬁed diet that con-
tained the following (g/kg): 200 casein, 530 sucrose, 100
cellulose, 100 fat blends, 35 vitamin mix, and 35 mineral mix
and a free access to water was allowed. Rats were subjected
to a 12:12-h daylight/darkness. They were observed for
15 days prior to commencing treatment to ensure adequate
adaptation.Induction of ovarian failure and injection of stem cells
Group I includes 10 rats, which were chosen randomly as a
negative control group (normal healthy rats) while the other
40 rats were included in the study group which in turn, were
administered a single intraperitoneal injection of 35 mg/kg of
Cyclophosphamide (CTX) (Endoxan, Baxter, Germany).
CTX destroys the existing pre- and post-meiotic germ cell
pools [18]. Three weeks after CTX, ovaries from two rats were
dissected from the anterior end of the uterus and the surround-
ing adipose tissues were carefully removed. Ovarian failure was
conﬁrmed after histopathological examination. One week after
conﬁrming induction of ovarian failure, the remaining rats in
the study group (n= 38) were randomly divided into 4 groups:
Group II (IOF) comprised 8 rats with induced ovarian fail-
ure that did not receive any more injections (a positive con-
trol group).
Group III rats (IOF + PBS, n= 10) were injected once
phosphate buffer saline (PBS) only.Group IV rats (IOF + hAM-MSCs, n= 10) were injected
intravenously once via the tail vein by hAM-MSCs
(5 · 106 cells) in a volume of 0.3 mL of 0.1 M PBS (pH 7.4).
Group V rats (IOF + AD-MSCs, n= 10) were injected
intravenously once via the tail vein by AD-MSCs (5 · 106 -
cells) in a volume of 0.3 mL of 0.1 M PBS (pH 7.4).
No transplant-related deaths were reported.
MSCs labeled with PKH26 Red Fluorescent Cell Linker
Kit (Sigma–Aldrich) were injected into the tail vein of all rele-
vant rat groups.
Estimation of serum FSH and E2
Serum FSH and E2 levels were assessed by ELISA kits
[CUSABIO, USA] every 15 days to assess ovarian function till
the end of the study (30 days after injection of stem cells).
Blood samples were collected in the morning from retro-
orbital vein of all rat groups; serum was separated and stored
at -20 C until analyzed.
Quantitative real time PCR for OCT4, Stra 8 and Integrin genes
expression in ovarian tissue
The 2 ovaries of each rat were harvested: one for histopatho-
logical examination and the other was made into frozen sec-
tions and then further processed for RNA extraction using
SV Total RNA Isolation system (Promega, Madison, WI,
USA) followed by Reverse Transcriptase for cDNA synthesis
(#K1621, Fermentas, USA) and qRT-PCR for OCT4, Stra 8
and Integrin beta-1 gene expression in ovarian tissue.
Histopathology was assessed by hematoxylin and eosin stained
tissues prepared parafﬁn impeded sections 30 days after stem
cells transplantation.
Real-time quantitative analyses
The relative abundances of the mRNA species were assessed
by the SYBR Green method using StepOnePlus Real-
Time PCR Systems (Applied Biosystems, Foster City, CA,
USA). The PCR primers used were designed with Gene
Runner Software (Hastings Software Inc., Hastings, NY,
USA) from RNA sequences in GenBank (Table 1). All of
the primer sets had a calculated annealing temperature of
60 C. Quantitative RT-PCR analyses were performed in
duplicate in a 25-lL reaction volume consisting of 2 · SYBR
Green PCR Master Mix (Applied Biosystems, USA), 900
nM of each primer, and 2–3 lL of cDNA. The ampliﬁcation
conditions were 2 min at 50 C, 10 min at 95 C, and 40 cycles
of denaturation at 95 C for 15 s and annealing/extension at
236 H. Fouad et al.60 C for 10 min. Data from the real-time assays were calcu-
lated by Software version 1.7 (PE Biosystems, Foster City,
CA, USA). The relative expression levels of Oct-4, Stra8 and
integrin beta-1 were calculated by the comparative Ct method
as stated by the manufacturer recommendations (Applied
Biosystems, USA).
Statistical analysis
Statistical Package for Social Studies (SPSS) program version
16.0.1 (SPSS Inc., Chicago, IL, USA) was used. Numerical
data were expressed as mean ± standard deviation. For
comparisons between treatment groups, the null hypothesis
was tested by a single-factor ANOVA. Multiple comparisons
were conducted using Tukey–Kramer test post hoc tests.
Comparisons were considered statistically signiﬁcant if p< 0.05.Results
In vitro study
Identiﬁcation, homing and characterization of hAM-MSCs and
AD-MSCs
hAM-MSCs and AD-MSCs were identiﬁed in culture by their
fusiform ﬁbroblast like-structure (Fig. 1).
Homing of PKH26 ﬂuorescent labeled hAM-MSCs and
AD-MSCs was detected in ovarian tissue by ﬂuorescent micro-
scope (Fig. 2).
Flow cytometric characterization analyses of hAM-MSCs
and AD-MSCs showed that hAM-MSCs were negative for
CD34- and were uniformly positive for CD29+ CD44+. AD-
MSCs were negative for CD45- and were uniformly positive
for CD90+ CD73+ (Fig. 3).Fig. 1 Isolated and cultured hAM-MSCs (plates A, B, C) and AD-M
and E) Stem cells reached 40–50% conﬂuence at 7 days, (C and F) StIn vivo study
E2 levels were assessed 15 days and 30 days after injection of
hAM-MSCs and AD-MSCs. Results showed that there was
a signiﬁcant decrease in E2 levels in IOF and in IOF + PBS
groups versus control (15.5 ± 0.78 and 15 ± 0.79 after
15 days versus 50.35 ± 21.8 in control rats, p< 0.001 and
13.1 ± 1.6 and 13.4 ± 1.4 after 30 days versus 54.1 ± 15.8
in control rats respectively, p< 0.001). The use of either
hAM-MSCs or AD-MSCs led to a signiﬁcant elevation in E2
levels with more superior therapeutic effects with hAM-
MSCs as compared to AD-MSCs (61.2 ± 11.5, p< 0.05 and
30.5 ± 12.6, p< 0.01 after 15 days versus 50.35 ± 21.8 in
control rats and 64.1 ± 7.9; non-signiﬁcant difference and
38.9 ± 10.2, p< 0.01 after 30 days versus 54.1 ± 15.8 in con-
trol rats respectively) (Table 2 and Fig. 4).
FSH levels were assessed 15 days and 30 days after injection
of hAM-MSCs and AD-MSCs. Results showed that there was
a signiﬁcant elevation of FSH levels in POF and in
POF+ PBS groups versus control group (82.2 ± 19.8 and
83.6 ± 20.1 versus 36.6 ± 8.0 in control rats, p< 0.001 after
15 days, 89.3 ± 20.3 and 90 ± 20.4 versus 39.6 ± 7.4 in con-
trol rats after 30 days respectively, p< 0.001). The use of
hAM-MSCs led to a signiﬁcant decrease in FSH levels as com-
pared to POF and POF + PBS groups (62.3 ± 21.7 after
15 days, p< 0.05 and 58 ± 9.4 after 30 days, non-signiﬁcant
difference versus 36.6 ± 8.0 and 39.6 ± 7.4 in control rats).
The use of AD-MSCs did not lead to decrease in FSH levels
as compared to control and IOF rat groups. (78.6 ± 15.9 after
15 days, p< 0.01 and 82.1 ± 9.5 after 30 days, p< 0.01 ver-
sus 36.6 ± 8.0 and 39.6 ± 7.4 in control rats, p< 0.05)
(Table 2 and Fig. 5).
As regards gene expression, results showed that there was a
signiﬁcant downregulation of OCT-4, Stra8 and integrin beta-1SCs (plates D–F): (A and D) Stem cells propagated for 2 days, (B
em cells reached 80–90% conﬂuence at 14 days.
Fig. 2 Homing of PKH26 ﬂuorescent labeled hAM-MSCs (plates A and B) and AD-MSCs (plates C and D) in ovarian tissues of rat.
Fig. 3 Flow cytometric characterization analyses of hAM-MSCs (upper plates) and AD-MSCs (lower plates). hAM-MSCs were
negative for CD34- and were uniformly positive for CD29+ CD44+. AD-MSCs were negative for CD45 and were uniformly positive for
CD90+ CD73+.
Amniotic membrane stem cells vs. adipose stem cells in ovarian failure 237in IOF (0.17 ± 0.09, 0.14 ± 0.03, 0.16 ± 0.02 respectively)
and in IOF + PBS (0.21 ± 0.04, 0.14 ± 0.03, 0.16 ± 0.03)
groups versus control (0.25 ± 0.06, 0.38 ± 0.1, 0.87 ± 0.18,
non-signiﬁcant changes with OCT-4, p< 0.05 for Stra8 and
p< 0.01 for integrin beta-1). The use of either hAM-MSCs
or AD-MSCs led to a signiﬁcant elevation of all genes with
more superior effect with hAM-MSCs (0.59 ± 0.09,p< 0.01, 0.69 ± 0.09, p< 0.01, 2 ± 0.4, p< 0.001) versus
AD-MSCs regarding integrin beta-1 gene only (0.39 ± 0.07,
0.43 ± 0.08, 0.45 ± 0.07, p< 0.01 for all genes) (Table 2
and Fig. 6).
As regards the total number of ovarian follicles and cor-
pora lutea in a cross section of the right ovarian in each of
















































































































































































































































































































































































































































































































































































































238 H. Fouad et al.signiﬁcant decrease in their numbers in IOF and in
IOF + PBS rat groups as compared to control group (5 and
5 versus 15 in control, p< 0.001). The use of either hAM-
MSCs or AD-MSCs led to a signiﬁcant elevation in ovarian
follicles and corpora lutea numbers when compared to IOF
rat groups (19, p< 0.001 and 12, p< 0.01 versus 5 in IOF
groups) and normalization of their numbers when compared
to control rat group (Table 2 and Fig. 7).
As regards histopathology examination, results showed
that IOF and IOF + PBS exhibited a decrease in number of
ovarian follicles with no oocytes inside, evidence of ﬁbrosis
and cystic changes (Fig. 8).
The use of either hAM-MSCs or AD-MSCs led to an evi-
dent increase in numbers of maturing follicles and corpora
lutea with apparent oocytes inside (Fig. 9).Discussion
Cyclophosphamide is an alkylating agent that induces the for-
mation of intra chain and inter chain DNA cross linking
resulting in interference with DNA replication specially in
rapidly dividing cells. It is well known that cyclophosphamide
massively eliminates granulosa cells [19] which are needed for
oocyte survival and follicle development. In the present study
cyclophosphamide was used to induce experimental model of
ovarian failure in rats. Ovarian failure was conﬁrmed in our
study by histopathological examination, the signiﬁcant
decrease in E2 levels, the signiﬁcant increase in FSH levels
and the signiﬁcant decrease in numbers of ovarian follicles
and corpora lutea in ovarian tissues. These ﬁndings were also
reported in a recent study [20] that conﬁrmed the exhaustion of
primordial follicles and follicular atresia with severe impair-
ment in ovarian function which resulted in POF after
cyclophosphamide treatment in mice.
In this study, we demonstrated that both of hAM-MSCs
and AD-MSCs signiﬁcantly increased the number of ovarian
follicles and corpora lutea and restored certain fertility param-
eters such as E2 and FSH levels in a rat model of POF induced
by cyclophosphamide. However, hAM-MSCs showed more
signiﬁcant therapeutic effects than AD-MSCs regarding all
the assessed parameters. Similar studies reported that amniotic
stem cells have great potential to differentiate into primitive
oocyte and participate in folliculogenesis within ovaries of
induced ovarian failure [20]. As regards the superior therapeu-
tic effects of hAM-MSCs versus AD-MSCs, this ﬁnding can be
explained by the multilineage potentials of amniotic membrane
stem cells and also the presence of side population cells (SP
cells) in human amniotic membranes. SP cells have multilin-
eage potentials to several cell lineages with unique immunolog-
ical characteristics such as HLA I (-)/II (-) or HLA I+/II (-)
[21].
Previous studies demonstrated that follicular atresia is
mainly caused by apoptosis of follicular cells, particularly
granulosa cells which are essential for follicular development
[22]. The therapeutic effects of hAM-MSCs on ovarian func-
tion resulted from paracrine secretion of some trophic factors
such as TGF-b [23], vascular endothelial growth factor [24],
and glia cell derived neurotrophic factor [25], that are essential
for follicular development and can inhibit follicular cell atresia
and follicles apoptosis [26,27]. These ﬁndings agreed with our
results that demonstrated the signiﬁcant increase in number of
Fig. 4 Serum E2 levels 15 days and 30 days after stem cells
injection in the studied groups. * signiﬁcant p value < 0.05 versus
control group. # signiﬁcant p value < 0.05 versus IOF group. Y
axis represents E2 levels in pg/mL.
Fig. 5 Serum FSH levels 15 days and 30 days after stem cells
injection in the studied groups. * signiﬁcant p value < 0.05 versus
control group. # signiﬁcant p value < 0.05 versus IOF group. Y
axis represents FSH levels in mIU/mL.
Fig. 6 Relative gene expressions of Oct-4, Stra 8 and Integrin-
beta-1 in the studied rat groups. * signiﬁcant p value < 0.05 versus
control group. # signiﬁcant p value < 0.05 versus IOF group. Y
axis represents relative gene expression values.
Fig. 7 The total number of ovarian follicles and corpora lutea in
a cross section of the right ovary in each studied rat groups. *
signiﬁcant p value < 0.05 versus control group. # signiﬁcant p
value < 0.05 versus IOF group. Y axis represents the number of
ovarian follicles in each studied rat group.
Amniotic membrane stem cells vs. adipose stem cells in ovarian failure 239ovarian follicles, the signiﬁcant increase in E2 levels and the
signiﬁcant decrease in FSH levels in IOF rat groups that
received either hAM-MSCs or AD-MSCs when compared to
untreated IOF rat groups. However, the assessment of the
paracrine trophic factors was not evaluated in our study.
Other studies reported similar ﬁndings, and Wang and his
colleagues [28] used hAECs to restore ovaries of
chemotherapy-induced ovarian failure in mice. The trans-
planted hAECs homed to mice ovaries and survived, differen-
tiated into granulosa cells. The restored ovarian cells
developed follicles at all stages. Lai et al. [2] suggested that
the transplanted hAFCs differentiated into granulosa, not
germ cells and that hAFCs directed follicle formation and
may enhance folliculogenesis via indirect tropism on ovariantissue in the chemically damaged mice ovary as evidenced by
increased expression of AMH after hAFCs transplantation
in the ovaries of sterilized mice. Conversely, AMH expression
is negative in the positive control groups.
As regards gene expressions in the present study, there was
a non-signiﬁcant decrease in OCT4 levels in IOF groups.
However, there was a signiﬁcant elevation in OCT4 levels in
IOF rat groups that received hAM-MSCs and AD-MSCs.
Gene expression of OCT4 is one of the molecular triggers
involved in the commitment to meiosis [29]. This fact is also
supported by Bahmanpour et al. [30] who thought that a
Fig. 8 A cross section in the right ovary of a rat from the IOF group showing only 6 follicles, 3 of them are cystic with no oocyte inside
(H & E) (left plate) and a cross section in the right ovary of a rat from the IOF + PBS group showing no follicles or corpora lutea; ﬁbrosis
is evident with Masson’s trichome (right plate).
Fig. 9 A cross section in the right ovary of a rat from the IOF + AM-MSCs group (upper plates) and IOF + AD-MSCs group (lower
plate) showing many mature follicles and corpora lutea with apparent oocytes inside them (upper plates).
240 H. Fouad et al.decrease in the number of primordial germ cell and an increase
in atretic and antral follicles could be attributed to the lower
expression of OCT4. On the same way Abdel Aziz et al. [31]
proved increased expression of Oct4 in the rats with azoosper-
mia when they received BM-MSCs. Moreover, the authors sta-
ted that MSCs could transdifferentiate into premeiotic and
postmeiotic cells when transplanted in a suitable microenvi-
ronment niche for germ cells development [31]. Stra8 and its
inducer, retinoic acid, regulate meiotic initiation in both sper-
matogenesis and oogenesis in mice [13].
More noteworthy, the observed signiﬁcant increase in the
OCT4 gene expression in hAM-MSCs and the AD-MSCs rat
groups means completion of the prophase I of meiotic division
and oocyte growth. These concepts were supported by Pesce
et al. [29].
As regards integrin beta-1 (CD29), there was a signiﬁcant
decrease in its levels in IOF rat groups. There was a signiﬁcant
increase in hAM-MSCs and AD-MSCs rat groups when com-
pared to IOF groups. The observed signiﬁcant increase in
intergrin beta-1 in hAM-MSCs and AD-MSCs rat groups
may suggest that stem cell transplantation may induce differ-
entiation of the oogonia to produce more mature oocytes.
Similar to our ﬁndings, Phillips et al. [32] detected increased
expression of b1 integrin when the human spermatogenetic
stem cells from azoospermia patients were induced to make
sperm-like cells (became more differentiated). Also AbdelAziz et al. [31] proved increased expression of integrin b1 in
the rats with azoospermia when they received BM-MSCs.
Stra8 is a speciﬁcally expressed gene in mammalian germ
cells. Germ cells undergo transition from mitosis to meiosis
during the activation of transcription of Stra8 and Rec8, which
is required for meiotic DNA replication and the subsequent
processes of meiotic prophase [12,13,33].
In the present study, Stra8 gene expression showed a signif-
icant decrease in IOF rat groups versus control group, whereas
there was a signiﬁcant increase in its levels in hAM-MSCs and
AD-MSCs rat groups when compared to IOF rat groups indi-
cating increased entry in meiotic division to generate oocytes
with subsequent improvement in the oogenesis. These results
agree with Niikura et al. [34] who stated that increased Stra8
gene expression is related to neo-oogenesis induction in young
female mice. Similar to our results Abdel Aziz et al. [31] proved
increased expression of Stra8 in the rats with azoospermia
when they received BM-MSCs.Conclusions
Administration of either hAM-derived MSCs or AD-MSCs
exerts a signiﬁcant therapeutic efﬁcacy on chemotherapy
induced ovarian insult in rats. hAM-MSCs exert higher thera-
peutic efﬁcacy as compared to AD-MSCs.
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